UnratedDrug recall · FDA · Published August 20, 2025
Major Pharmaceuticals Carvedilol Tablets Recall: NNCI Impurity Risk
Major Pharmaceuticals recalls 12.5 mg Carvedilol Tablets due to NNCI impurity exceeding FDA limits. Affected units may pose health risks; contact for return instructions.
“Major Pharmaceuticals Carvedilol Tablets Recall: NNCI Impurity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31862-major-pharmaceuticals-carvedilol-tablets-recall-nnci-impurity-risk. Based on FDA recall #D-0594-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0594-2025%22&limit=1).
The FDA announced on 2025-08-20 that Major Pharmaceuticals is voluntarily recalling Carvedilol Tablets USP, 12.5 mg due to CGMP deviations resulting in N-Nitroso Carvedilol Impurity-1 levels exceeding the recommended limit. The recall affects 26,628 cartons distributed nationwide.
The recall is due to CGMP deviations where results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity were observed to be above the FDA-recommended limit of NMT 4.0 ppm.
Context
GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has 14 other recalls on record since 2023-05-31. Other recent recalls of similar products include Major Chlorpromazine Tablets Recall (2025-09-12), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (2025-09-02), and Major Pharmaceuticals recalls 10mg ChlorproMAZINE tablets due to impurity risk (2025-04-14). Other recent recalls of similar products include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (2026-01-21), Breckenridge Duloxetine Capsules Recall (2026-04-21), and Zydus Mirabegron 25mg Tablets Recall (2026-08-05).
How to tell if you have this one
Check for the product name 'Carvedilol Tablets USP, 12.5 mg, 100-tablets, (10x10) cartons' with NDC 0904-7307-61 and lot number T05693.
Brand
Major Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product's NDC code (0904-7307-61) and lot number (T05693) to confirm it is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was distributed nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 7 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0594-2025 (August 20, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0594-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.